Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
BIDU-SW
09888
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (FY)Mar 31, 2023 | |
|---|---|---|---|
| Operating cash flow (Indirect Method) | |||
| Cash from operating activities | 19.43%-2.32B | 33.85%-2.88B | -4.36B |
| Net profit before non-cash adjustment | 65.02%-1.41B | -17.06%-4.04B | ---3.45B |
| Total adjustment of non-cash items | -140.27%-664M | 313.60%1.65B | ---772M |
| -Depreciation and amortization | 51.58%529M | -12.97%349M | --401M |
| -Reversal of impairment losses recognized in profit and loss | --0 | --1.6B | --0 |
| -Disposal profit | --0 | ---75M | --0 |
| -Net exchange gains and losses | -149.28%-1.74B | 64.53%-698M | ---1.97B |
| -Other non-cash items | 14.68%547M | -40.00%477M | --795M |
| Changes in working capital | 50.10%-244M | -270.45%-489M | ---132M |
| -Change in receivables | ---- | 58.04%-446M | ---1.06B |
| -Change in payables | 52.20%-250M | -253.38%-523M | ---148M |
| -Provision for loans, leases and other losses | -82.35%6M | 112.50%34M | --16M |
| Dividends paid (cash flow from operating activities) | |||
| Dividends received (cash flow from operating activities) | |||
| Interest paid (cash flow from operating activities) | 6.47%-188M | 8.22%-201M | -219M |
| Interest received (cash flow from operating activities) | 14.10%89M | 78M | 0 |
| Tax refund paid | 193.79%151M | 56.49%-161M | -370M |
| Other operating cash inflow (outflow) | 1M | 0 | 0 |
| Operating cash flow | 28.33%-2.27B | 35.99%-3.17B | ---4.95B |
| Investing cash flow | |||
| Net PPE purchase and sale | 25.66%-84M | 86.86%-113M | ---860M |
| Net intangibles purchase and sale | -215.41%-2.38B | 27.53%-753M | ---1.04B |
| Net investment product transactions | --0 | --0 | --0 |
| Net changes in other investments | -154.17%-13M | 182.76%24M | ---29M |
| Investing cash flow | -193.59%-2.47B | 56.33%-842M | ---1.93B |
| Financing cash flow | |||
| Net issuance payments of debt | -1,036.11%-2.36B | -84.31%252M | --1.61B |
| Net common stock issuance | --5.31B | --0 | --211M |
| Increase or decrease of lease financing | 20.54%-89M | -15.46%-112M | ---97M |
| Issuance fees | ---31M | --0 | ---- |
| Net other fund-raising expenses | -110.53%-2M | -99.65%19M | --5.4B |
| Financing cash flow | 1,679.25%2.83B | -97.77%159M | --7.12B |
| Net cash flow | |||
| Beginning cash position | -25.16%10.17B | 10.08%13.59B | --12.35B |
| Current changes in cash | 50.32%-1.91B | -1,671.02%-3.85B | --245M |
| Effect of exchange rate changes | -71.79%121M | -57.06%429M | --999M |
| Cash adjustments other than cash changes | ---- | ---- | --1M |
| End cash Position | -17.60%8.38B | -25.16%10.17B | --13.59B |
| Free cash flow | -17.26%-4.73B | 41.10%-4.03B | ---6.85B |
| Currency Unit | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |